Hers Review: Women's GLP-1 From a Leading Telehealth Brand

Overview

Hers is the women's health arm of Hims & Hers Health, Inc. (NYSE: HIMS), one of the largest and most recognized telehealth companies in the United States. The publicly traded company has built a massive platform serving millions of customers across skincare, hair loss, mental health, sexual health, and now — GLP-1 weight management.

Hims & Hers recently made major headlines by announcing aggressively priced compounded semaglutide and tirzepatide, positioning themselves as a direct challenger to traditional pharmaceutical pricing on brand-name GLP-1 drugs like Ozempic and Mounjaro. The company has been vocal about making weight loss medications more accessible and affordable, and has actively pushed back against FDA efforts to restrict compounded versions of these medications.

This bold stance has resonated with patients and investors alike, reinforcing Hers' position as a major player in the GLP-1 space. For women seeking weight management treatment, Hers offers the security of a well-regulated, publicly traded company combined with the convenience of a premium digital health experience — all backed by board-certified physicians specializing in women's health.

Medications & Pricing

Hers offers two primary compounded GLP-1 medications for weight management:

As part of Hims & Hers' mission to challenge big pharma pricing, these compounded medications are offered at a fraction of the cost of brand-name alternatives like Ozempic and Mounjaro. All medications are prescribed by board-certified physicians and dispensed through licensed pharmacies with free, discreet shipping.

How It Works

Platform Experience

One of Hers' strongest advantages is its digital experience. The app is polished, intuitive, and among the best in the telehealth space. Prescription management, provider messaging, order tracking, and health resources are all seamlessly integrated into a single platform.

Beyond GLP-1 weight management, Hers offers a holistic suite of women's health services including skincare, hair loss treatments, mental health support, and sexual health — making it a one-stop platform for women who want to manage multiple health needs in one place. This ecosystem approach means existing Hers customers can easily add GLP-1 treatment to their existing care.

Pros & Cons

Who Is It For?

Hers is ideal if:

• •You're a woman who wants a trusted, established brand for GLP-1 treatment
• •You already use Hers for other health services (skincare, mental health)
• •You value a polished app experience and brand recognition
• •You're in any US state and want convenient GLP-1 access
• •You prefer a publicly traded, well-regulated telehealth company

Our Verdict

Hers brings massive brand trust and a premium experience to women's GLP-1 treatment. As part of publicly traded Hims & Hers Health, it offers the security of a well-regulated, established company that's making bold moves to make GLP-1 medications more accessible. The app experience is among the best in telehealth, and the holistic platform means you can manage multiple health needs in one place.

However, at $199/mo it's pricier than budget-focused providers. CoreAge Rx offers compounded semaglutide from $99/mo with free 2-day shipping, making it a better value for cost-conscious patients. For those who want a premium brand experience from one of the biggest names in telehealth, Hers delivers.